biguanides has been researched along with Encephalitis Infection in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, G | 1 |
| Kalra, SK | 1 |
| Tejan, N | 1 |
| Ghoshal, U | 1 |
| Siddiqui, R | 1 |
| Aqeel, Y | 1 |
| Khan, NA | 1 |
2 reviews available for biguanides and Encephalitis Infection
| Article | Year |
|---|---|
Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebiasis; Amebicides; Biguanides; Central Nervous System Prot | 2020 |
The Development of Drugs against Acanthamoeba Infections.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amphotericin B; Animals; Antiprotozoal Agents; Azoles; Biguani | 2016 |